InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Evaxion A/S

EVAX Clue Score60
Denmark Fiscal year ends December CIK 0001828253
$3.00 -2.28% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.00 −63.94% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 5 Feb 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Operating income−5.6Net income−5.5Fiscal year 2019Operating income−10.9Net income−11.2EPS, diluted−0.81Fiscal year 2020Operating income−16.6Net income−15.0EPS, diluted−0.97Fiscal year 2021Operating income−25.8Net income−24.5EPS, diluted−1.26Fiscal year 2022Revenue0.0Operating income−25.3Net income−23.2EPS, diluted−0.98Fiscal year 2023Revenue0.1Operating income−22.2Net income−22.1EPS, diluted−0.81Fiscal year 2024Revenue3.3 +4,480.8%Operating income−14.7Net income−10.6Fiscal year 2025Revenue7.5 +125.1%Operating income−9.2Net income−7.7
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a 0.0 0.1 3.3 7.5
Growth +4,480.8% +125.1%
Operating income −5.6 −10.9 −16.6 −25.8 −25.3 −22.2 −14.7 −9.2
Net income −5.5 −11.2 −15.0 −24.5 −23.2 −22.1 −10.6 −7.7
Growth
EPS, diluted n/a −0.81 −0.97 −1.26 −0.98 −0.81 n/a n/a
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Operating margin−30,406.8%Net margin−30,308.2%Free cash flow margin−24,353.4%Fiscal year 2024Operating margin−440.6%Net margin−316.0%Free cash flow margin−387.0%Fiscal year 2025Operating margin−122.7%Net margin−102.4%Free cash flow margin−88.2%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a n/a −30,406.8% −440.6% −122.7%
Net margin n/a n/a n/a n/a n/a −30,308.2% −316.0% −102.4%
Free cash flow margin n/a n/a n/a n/a n/a −24,353.4% −387.0% −88.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−2.0Capital expenditure−0.0Free cash flow−2.0Fiscal year 2019Operating cash flow−7.0Capital expenditure−0.1Free cash flow−7.1Fiscal year 2020Operating cash flow−12.4Capital expenditure−0.1Free cash flow−12.6Fiscal year 2021Operating cash flow−21.9Capital expenditure−1.3Free cash flow−23.2Fiscal year 2022Operating cash flow−25.8Capital expenditure−0.3Free cash flow−26.1Fiscal year 2023Operating cash flow−17.7Capital expenditure−0.1Free cash flow−17.8Fiscal year 2024Operating cash flow−12.9Capital expenditure0.0Free cash flow−12.9Fiscal year 2025Operating cash flow−6.6Capital expenditure−0.0Free cash flow−6.6
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −2.0 −7.0 −12.4 −21.9 −25.8 −17.7 −12.9 −6.6
Capital expenditure −0.0 −0.1 −0.1 −1.3 −0.3 −0.1 0.0 −0.0
Free cash flow −2.0 −7.1 −12.6 −23.2 −26.1 −17.8 −12.9 −6.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securitiesTotal debt
Fiscal year 2018Cash and securities7.4Total debt8.6Net cash (debt)−1.1Shareholders’ equity−0.9Fiscal year 2019Cash and securities9.6Shareholders’ equity9.4Fiscal year 2020Cash and securities5.8Shareholders’ equity7.0Fiscal year 2021Cash and securities32.2Total debt1.2Net cash (debt)31.0Shareholders’ equity32.4Debt to equity0.04Fiscal year 2022Cash and securities13.2Total debt8.0Net cash (debt)5.2Shareholders’ equity8.3Debt to equity0.96Fiscal year 2023Cash and securities5.6Total debt8.6Net cash (debt)−3.1Shareholders’ equity−4.7Fiscal year 2024Cash and securities6.0Total debt8.2Net cash (debt)−2.2Shareholders’ equity−1.7Fiscal year 2025Cash and securities23.2Total debt5.5Net cash (debt)17.7Shareholders’ equity17.0Debt to equity0.32
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and securities 7.4 9.6 5.8 32.2 13.2 5.6 6.0 23.2
Total debt 8.6 n/a n/a 1.2 8.0 8.6 8.2 5.5
Net cash (debt) −1.1 n/a n/a 31.0 5.2 −3.1 −2.2 17.7
Shareholders’ equity −0.9 9.4 7.0 32.4 8.3 −4.7 −1.7 17.0
Debt to equity n/a n/a n/a 0.04 0.96 n/a n/a 0.32

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−2.0 −7.0 −12.4 −21.9 −25.8 −17.7 −12.9 −6.6
Growth
Investment
−0.0 −0.1 −0.1 −1.3 −0.3 −0.1 0.0 −0.0
calc −2.0 −7.1 −12.6 −23.2 −26.1 −17.8 −12.9 −6.6
Growth
0.0 −0.1 −0.4 −1.3 −0.3 −0.1 −0.0 −0.0
Financing
9.0 9.5 8.8 49.8 7.9 10.7 13.1 22.4

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.